Ticker brief
ELAB
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
6
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-29 → 2026-07-01 · now +0.40 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @dmdt14 | C | +0.77 | 1 | +0.25 |
| @UMiLiveOfficial | C | · | 1 | +0.25 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @JLportfolio1 | C | +2.60 | 1 | +0.55 |
| @ABBONews | C | · | 1 | +0.45 |
| @KevOfMomentum | C | -2.23 | 1 | +0.25 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @KevOfMomentum | +0.25 | Says ELAB gave the perfect entry today, a past setup recap. | · | tweet ↗ |
| 2026-07-01 | @ABBONews | +0.45 | Subsidiary reports positive Phase III AI-driven drug discovery collaboration results. | · | tweet ↗ |
| 2026-07-01 | @JLportfolio1 | +0.55 | ELAB announced positive Phase III results; author watches reclaim levels on heavy volume. | · | tweet ↗ |
| 2026-07-01 | @OpenOutcrier | +0.50 | Positive Phase III AI-driven drug discovery program results announced. | · | tweet ↗ |
| 2026-07-01 | @UMiLiveOfficial | +0.25 | Base forming, volume improving, and risk/reward interesting, but no confirmation yet. | · | tweet ↗ |
| 2026-06-29 | @dmdt14 | +0.25 | Lists activity, support 2.10, resistance 2.24, under watch if support holds. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.